In a year made difficult by the pandemic, the life sciences and healthcare sector in Catalonia reached an exceptional milestone:€226 million in investment, the most ever in its history.
The call is now open for the program that allows companies to post their innovation challenges on an online platform and get proposals from academia and research.
To answer this ambitious goal, we have developed the analysis 'The BioRegion of Catalonia: road to €500M in investment per year" which presents questions and answers about this possible ecosystem scaling.
The sector’s top place for job offers in Catalonia.
More than 1,000 companies and a wide network of universities, hospitals and research entities.
FORMAT ONLINE
Antoni Matilla is the founder of the spinoff Biointaxis as well as Director of the Neurogenetics Research Unit at the Institute for Health Science Research Germans Trias i Pujol (IGTP). He is a researcher, doctor and entrepreneur with over thirty years of experience in research and business management in Catalonia, United States and United Kingdom. Since 1990, his research has focused on understanding and curing hereditary ataxias, a group of minority hereditary neurodegenerative diseases that have no cure so far.
